Search by Drug Name or NDC

    NDC 46063-0552-12 Relispray Antifungal Powder 0.02 g/g Details

    Relispray Antifungal Powder 0.02 g/g

    Relispray Antifungal Powder is a TOPICAL AEROSOL, SPRAY in the HUMAN OTC DRUG category. It is labeled and distributed by Midas-Care Pharmaceuticals Pvt. Ltd.. The primary component is MICONAZOLE NITRATE.

    Product Information

    NDC 46063-0552
    Product ID 46063-552_692ad959-7088-4fe5-9ff7-66b1e26f517f
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Relispray Antifungal Powder
    Proprietary Name Suffix n/a
    Non-Proprietary Name Miconazole Nitrate
    Product Type HUMAN OTC DRUG
    Dosage Form AEROSOL, SPRAY
    Route TOPICAL
    Active Ingredient Strength 0.02
    Active Ingredient Units g/g
    Substance Name MICONAZOLE NITRATE
    Labeler Name Midas-Care Pharmaceuticals Pvt. Ltd.
    Pharmaceutical Class Azole Antifungal [EPC], Azoles [CS]
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH FINAL
    Application Number part333C
    Listing Certified Through 2024-12-31

    Package

    NDC 46063-0552-12 (46063055212)

    NDC Package Code 46063-552-12
    Billing NDC 46063055212
    Package 128 g in 1 CAN (46063-552-12)
    Marketing Start Date 2022-03-01
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 93434d3e-6fe4-4fe0-be4f-573d183bf527 Details

    Revised: 1/2022